After qualifying from Guys and St.Thomas’ hospitals in 1993 Dr Simcock completed his postgraduate medical training in the South East, including Brighton.
In 1997 he spent time working in palliative care in hospices and at The Royal Marsden hospital before moving to Charing Cross hospital as a Specialist trainee in Oncology. Over the next five years, he worked as an oncologist at St Thomas’s and Guys, Mount Vernon, Maidstone and Brighton.
In 2003 he travelled to Australia as a Clinical Research Fellow at the Sydney Cancer Centre working on technical radiotherapy of head and neck cancers.
In 2004 Dr Simcock took up a consultant position at The Sussex Cancer Centre. In Sussex, he treats breast and head and neck cancers. He is the Lead clinician for Breast Care at Brighton and Sussex University Hospitals NHS trust and Chair of the Sussex Cancer Network Breast Tumour Group. He is Chair of the Specialist Head and Neck Multidisciplinary team for Sussex and Sussex Cancer Network Lead Clinician for Head and Neck Cancer. In these roles, he has a responsibility for ensuring high-quality care is delivered to all cancer patients all of the time.
Special clinical interests
Breast cancer, including technical breast radiotherapy developments and cancer of the head and neck including technical developments.
Fellowship of Royal College of Radiologists 1999.
Membership of Royal College of Physicians (Ireland) 1997.
British Institute of Radiology.
European Society of Therapeutic Radiation Oncology.
American Society for Therapeutic Radiation Oncology.
British Oncology Association.
Current NHS posts
Consultant Clinical Oncologist at Sussex Cancer Centre.
Lead Clinician for Breast Care at Park Centre for Breast Care, Brighton.
Multidisciplinary working, acupuncture therapy as supportive treatment in cancer (National Chief Investigator of ARIX study), Diet and Lifestyle (Local Principal investigator for diet and lifestyle study) HPV in head and neck cancer, Novel agents in breast cancer and head and neck (in 2011: local Principal Investigator for DCARE , CARIATIDE, EGF 988, TNT trials).